This results in transiently advantageous changes in the β-adrenergic receptor (β-AR)- and cyclic adenosine monophosphate (cAMP)-dependent inotropic response of cardiomyocytes4 but transforms into a maladaptive decrease of myocardial responsiveness at more advanced stages of HF.6 This evidence concerns the gene ADRB2 and hydrops fetalis.